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Abstract
Background: Occurrence and consequence of cord blood (CB) vitamin D insufficiency/deficiency has not been
adequately explored despite rising concern regarding this topic in pediatrics. This study was designed to determine the
rate, maternal risk factors, and clinical outcomes in infants in association with vitamin D insufficient/deficient status at birth.
Methods: American Academy of Pediatrics (AAP) defined levels (ng/mL) were utilized to categorize the vitamin D status in
CB samples as deficient (5–15), insufficient (16–20), and sufficient (21–100). We used descriptive statistics and multiple
regression models to identify the rate and factors associated with vitamin D deficiency/insufficiency and related outcomes
in the enrolled mother-infant pairs.
Results: This prospective study was conducted at a single center on postpartum women and their infants. Vitamin D
deficiency and insufficiency was recorded in 38.9 and 29.8% respectively of the 265 CB samples. Deficient CB vitamin D
levels in infants were associated with maternal Black, Hispanic, or Asian race/ethnicity, younger age, and increased number
of pregnancies. The likelihood for infants to be born with an insufficient vitamin D level increases with younger maternal
age and the number of pregnancies as well as Asian ethnicity. We did not find an association between the vitamin D
status at birth and pre-discharge clinical characteristics of the neonates.
Conclusions: The likelihood for an infant to be born with vitamin D deficiency/insufficiency is relatively high and is
related mainly to younger maternal age, gravidity, and non-White race/ethnicity. Our findings raise a question
regarding the adequacy of the AAP recommended vitamin D supplementation requirements without knowing the
infant’s vitamin D status at birth.
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Background
Characterization of the vitamin D status in the maternal-
fetal-neonatal interface is clinically important because of
the increased rates of detection of vitamin D insufficiency
in cord blood (CB) and the associated risk for health com-
plications in infants and children [1, 2], including but not
limited to rickets [3], infectious and allergic diseases, and
type 1 diabetes [4–6]. Assessing vitamin D status using
CB is a challenge as the optimal level of vitamin D in
children is still the subject of discussion [7]. For the child
population, t he American Academy of Pediatrics (AAP)
defines a vitamin D level of 20 ng/mL as sufficient [8].
The Drug and Therapeutics Committee of the Lawson
Wilkins Pediatric Endocrine Society classified vitamin D
levels < 5 ng/mL in children as severely deficient, 5–
15 ng/mL as deficient, and 15–20 ng/mL as insufficient
[9]. However, the Clinical Practice Guidelines published
by the Endocrine Society recommends that 30 ng/mL of
vitamin D in children and adults should be considered suf-
ficient and classifies levels below 20 ng/mL (50 nmol/L)
and 21–29 ng/mL (55–75 nmol/L) as deficient and
insufficient, respectively [10].
Several studies were designed to identify the rates of
vitamin D insufficiency in CB of infants born to different
maternal populations. A CB vitamin D level ≤ 20 ng/mL
was detected in 84% of African American and 22% of
White infants born in Florida [11], 55% of infants from
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the mixed ethnic population in Belgium [12], and 55.5%
of infants born to Italian women and 77.3% of the immi-
grant mothers in Italy from Latin, Asian and African
countries [13]. Bodnal et al. [14] reported CB vitamin D
deficiency (<15 ng/mL) and insufficiency (15–32 ng/mL)
in 45.6 and 46.8% of African American infants, and 9.7
and 56.4% of White neonates from the northern United
States. Vitamin D deficiency [less than 25 nmol/L
(<10 ng/mL)] and insufficiency [between 25 and 50 nmol/
L (10–20 ng/mL)] have been reported in CB samples of
25 and 44% infants born to European, and 75 and 21% of
infants born to non-European mothers in Netherlands
[15]. A population-based study from Australia reported
vitamin D levels of ≤ 10 ng/mL (≤25 nmol/L) in 11% of
the cord blood samples [16]. CB samples from multiethnic
infants living in the tropical region showed deficient vita-
min D levels (<20 ng/mL) in 28% and insufficient levels
(20–30 ng/mL) in 50% of the cases [17].
Differences in the classification [8–10] used to assess
the infants’ vitamin D status and strong dependence of
their vitamin D pool on maternal vitamin D levels [18]
may be responsible for the wide variability in the reported
rates of vitamin D deficiency/insufficiency in infants at
birth. Despite numerous publications that explored
vitamin D status in CB, further research is required to de-
termine the likelihood for detection of vitamin D insuffi-
ciency in CB of infants. Improved understanding of
factors associated with development of vitamin D defi-
ciency/ insufficiency will facilitate the creation and imple-
mentation of appropriate preventive strategies.
To the best of our knowledge, our study is the first
that in addition to identifying the rate, also estimates the
risk of vitamin D deficiency/insufficiency in the CB and
associated outcome in a diverse population of infants.
Methods
This prospective cohort study was conducted at a single
center on a non-random sample of postpartum women
who were aged more than 18 years old and delivered
healthy infants at Robert Wood Johnson University Hospital
between July 2014 and June 2015. The study was approved
by the Rutgers Robert Wood Johnson Medical School’s
Institutional Review Board. Signed informed consent by the
mother was required for participation in this study.
Clinical data collection
We used maternal and neonatal medical records to extract
significant demographic and medical information. A stan-
dardized data extraction tool was used to collect relevant
maternal (age, weight at delivery, race/ethnicity, insurance
status, use of prenatal vitamins and/or other medications,
evidence of pregnancy complications, mode of delivery)
and neonatal (gestational age, birth weight and length,
Apgar score, morbidity during birth hospitalization) demo-
graphic and clinical information.
Samples proceed and testing procedure
Leftover samples in lavender top EDTA (ethylenediamine-
tetraacetic acid) tubes from routine collection of CB for
identification of blood type in all infants born in the hos-
pital were used to test for vitamin D levels. The samples
were centrifuged to derive plasma that was divided into
three aliquots and stored in deep freezer at −70°∁ pending
simultaneous testing in a reference laboratory.
The reference laboratory used Advanced Liquid Chro-
matography/Tandem Mass Spectrometry (LC/MS/MS) to
measure total 25-hydroxyvitamin D [25(OH)D] along with
vitamin D3 and D2. This methodology differs from stand-
ard LC/MS/MS assays because it enables chromatographic
separation of the C3-epimer from 25-OH Vitamin D,
which is the low activity form of the potentially interfering
[25(OH) D3] metabolite [19]. It has been shown that the
C3-epimer of [25(OH) D3] accounts for up to 14 and 25%
of total levels of [25(OH) D3] in cord and infant blood,
respectively [20]. Hence, elimination of the low activity
form of [25(OH) D3] from the final report prevents false
elevation of results. Tested levels of calcidiol [25(OH)D]
and vitamin D components, including the ergocalciferol
(Vitamin D2) and cholecalciferol (Vitamin D3) were
expressed in ng/mL. The lowest detectable concentrations
were 4 ng/mL for both Vitamin D2 and D3. Vitamin D2
levels were undetectable (<4 ng/mL) in 99.9% of CB
samples. Therefore, the total level of CB vitamin D
measured in this study is equal to [25(OH)D3] levels,
which is the main contributor to the [25(OH)D] pool.
Data presentation and statistical analyses
The results of [25(OH) D] were analyzed as a continuous
variable and were also stratified with respect to the AAP’s
definition of vitamin D status [8, 9] as severe (<5 ng/mL)
or mild/moderate deficient (5–15 ng/mL), insufficient (16–
20 ng/mL), and sufficient (21–100 ng/mL). Because a se-
verely deficient CB Vitamin D level (<5 ng/mL) was found
in only one sample, it was merged with the group that
showed deficient [25(OH) D] levels. We performed analysis
of variance (ANOVA) and Chi-square test statistics to
compare continuous and categorical data between the
groups with respect to the infants’ vitamin D status at birth
defined as deficient, insufficient, and sufficient. Variables
with significant between-group variability (P value of less
than 0.05) were classified for inclusion into the multiple re-
gression models to estimate their independent role in the
development of vitamin D deficiency and insufficiency in
CB as compared to those with sufficient levels of vitamin
D. In addition multiple regression models were stratified
by race/ethnicity defined as White, Black, Hispanic, and
Asian. Mothers without information on race/ethnicity were
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excluded from subgroup analysis. Possible multicollinearity
of the predictive value of the variables included in the
regression model was assessed by estimation of variance
inflation factor (VIF/(1-R2)], where R2 is coefficient of
determination, and VIF above 2.5 was classed as indicative
of a possible linear dependence of the regression coefficient
with other predictors [21].
Data are presented as means, proportion (%), regression
coefficient (β) ± standard error (Std. Err. of β), and Odds
Ratio (OR) and 95% Confidence intervals (95% CI). Differ-
ence was considered significant if P value was less than
0.05. STATISTICA version 12.0 (StatSoft Inc, Tulsa, OK)
was used to analyze the data.
Results
Among the 360 enrolled mothers, a total of 265 mother-
infant pairs were included in the final analysis. The difference
is due to technical problems with collection of 92 leftover CB
samples, and insufficient quantity of the specimen for testing
of vitamin D levels in three CB samples. Complete demo-
graphic and clinical data collection was available for 265
mother-infant pairs. In 21 subjects (7.9%), maternal race/eth-
nicity information was not verifiable.
Characteristics of umbilical cord blood vitamin D status
CB levels of vitamin D were classified as deficient, insuffi-
cient, and sufficient in 95 (38.9%, 95%CI 33.0–44.8), 79
(29.8%, 95%CI 24.3–35.3), and 91 (34.3%, 95%CI 28.6–40)
infants, respectively. The mean and 95% CI of mean of CB
vitamin D levels in infants defined with sufficient, insuffi-
cient, and deficient levels was 27.3 ng/mL (26–28.5),
17.8 ng/mL (17.4–18.1), and 11.6 ng/mL (11–12.2), re-
spectively. As shown in Table 1, mothers of infants with
deficient and insufficient level of vitamin D in CB were
Table 1 Maternal demographics and clinical characteristics with respect to CB vitamin D status
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younger and had a greater number of pregnancies as com-
pared to mothers of infants with sufficient level of
[25(OH)D]. In addition, we identified significant variability
in the infant’s vitamin D level at birth due to maternal
race/ethnicity (Fig. 1). The highest prevalence of vitamin
D deficiency was recorded in CB of infants born to Black
mothers (61.8%) and vitamin D sufficiency in infants born
to White mothers (46.5%).
Factors associated with CB vitamin D status
Maternal race/ethnicity, age and gravidity were included
in the multiple regression models to identify factors asso-
ciated with detection of vitamin D deficiency (Model 1)
and insufficiency (Model 2) in infants’ CB. In these
models, the VIF indicates no multicollinearity between the
defined co-variances: 1.08 and 1.03 for race/ethnicity
(White vs. non-White), 1.03 and 1.06 for age, 1.07 and
1.01 for gravidity. Inclusion of maternal race/ethnicity
(White vs. non-White), age, and gravidity in the multiple
regression models revealed independent association of
vitamin D deficiency and insufficiency in the infant’s CB
with non-White maternal race/ethnicity, younger age, and
increased number of pregnancies (Table 1). When the
same variables were included in each race/ethnic group
(Table 2), the risk for detection of vitamin D deficiency in
CB of infants was associated with Black, Asian and
Hispanic race/ethnicity of the mothers. Risk for detection
of vitamin D insufficiency in CB of infants born to Black
or Hispanic mothers was comparable to those in White
neonates but higher in babies born to Asian mothers. A
comparable magnitude of the independent effect of mater-
nal age and gravidity on vitamin D status was identified in
each race/ethnicity model (data not presented).
Neonatal characteristics and CB vitamin D status
Among the 265 infants in this study, 6.4% were born at
gestational age between 37 and 34 weeks and 1.9% from
multiple gestations. Birth weight of the infants was not
less than 2030 g. In 3.8% of infants, the Apgar score at
1 min was less than 7; and 6.8% of the infants were admit-
ted to the neonatal intensive care unit. We found no sig-
nificant difference in the clinical characteristics of the
infants with regards to their CB vitamin D level (Table 3).
Discussion
We found that up to 45% infants are at risk for deficient
and 35% for insufficient levels of vitamin D. The approxi-
mated probability of an infant being born with a sufficient
vitamin D level as defined by the AAP for children [8] is less
than 40%. Importantly, the upper limit of vitamin D that is
defined as sufficient [8] could be suboptimal because vita-
min D levels of <30 ng/mL have been associated with
increased secretion of intact parathyroid hormone and
reduced intestinal calcium absorption in healthy adults
[22, 23]. While a vitamin D level of 20 ng/mL is considered
sufficient, maintenance of 30 ng/mL is recommended for
better health in children and adults [24] despite the lack of
clear evidence of an optimal concentration of vitamin D for
bone and general health. Because the main source of vita-
min D is vitamin D3 that is synthesized in the skin through
a photolytic reaction, the level of vitamin D depends on skin
pigmentation, use of sunscreens, coverage of sun-exposed
skin, seasonal factors, and geographic latitude [25–27].
Our findings confirmed previous reports showing an
increased risk for vitamin D deficiency in infants born to
mothers of non-White race/ethnicity [11, 14, 15, 28]. A
study that linked the mean levels of [25(OH)D] in 100 cord
plasma samples with maternal ethnicity reported higher
level in Caucasians as compared to Asians, Hispanics,
Pacific Islanders, and African Americans [17]. To the best
of our knowledge, no US study has compared the CB
vitamin D levels of infants with respect to the maternal
race/ethnicity. Moreover, the internal validity of the existing
studies is a subject for discussion because the independent
effect of maternal race/ethnicity on the vitamin D status
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%
Fig. 1 Cord blood 25(OH)D status and maternal race/ethnicity. Chi-square test statistics were used to compare CB vitamin status defined as deficient,
insufficient and sufficient with respect to maternal race/ethnicity
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have an association with the development of vitamin D de-
ficiency/insufficiency in infants at birth. We found that in-
dependently from the race/ethnicity, younger maternal age
and increased number of pregnancies were associated with
vitamin D deficiency and insufficiency in CB of the studied
infants. Cadario et al. [13] reported an association between
younger maternal age and diagnosis of vitamin D defi-
ciency. European data showed both, decreased risk and no
effect of parity on vitamin D insufficiency/deficiency in
mothers during pregnancy [29, 30]. Unadjusted analysis of
the association between clinical data and vitamin D levels
in the CB that was conducted on 241 mother-infant pairs
(72.6% black and 81.3% multiparous) revealed lower vita-
min D levels in the cord blood of nulliparous women [31].
Comparable to previous reports we found no difference
between the CB vitamin D status and maternal multivita-
min supplementation [30, 32]. However, others have re-
ported that the use of multivitamins, which usually include
400 IU vitamin D3, is associated with increased
concentrations of 25(OH)D in CB [4]. As in the study by
Bodnar et al. [14], we did not find an association between
the CB vitamin D level and season of birth.
In the present study, evaluation of the neonatal clinical
data did not reveal any obvious association between CB
vitamin D levels and neonatal health status during the
short period of birth hospitalization. However, there was a
tendency for a higher use of phototherapy in infants born
with vitamin D deficiency as compared to those with vita-
min D sufficiency (5.3 vs. 1.1%, one-sided P = 0.053). Gen-
erally, phototherapy is required in 1.4% of healthy born
neonates [33]. Vitamin D deficiency has been reported in
86% infants with pathological hyperbilirubinemia, and
43% of controls [34]. To the best of our knowledge, no
prior study has investigated the clinical status of neonates
in association with CB vitamin D levels.
We acknowledge the potential limitations of our study.
Maternal data that may correlate with neonatal vitamin D
levels at birth, including the pre-pregnancy weight [35],
skin color [13], and sun exposure during pregnancy [36]
were not collected. However, it is unlikely that these
limitations will affect the observed rate of vitamin D
deficiency and insufficiency seen at birth in the studied in-
fants. We did not find a difference between the maternal
weight at delivery and occurrence of vitamin D deficiency/
insufficiency in infants at birth. Moreover, a review of the
literature revealed that data obtained from questionnaires
regarding the assessment of sunlight exposure do not pre-
cisely estimate vitamin D status [37].
We would like to highlight the strengths of the present
report that include: (i) prospective observation of a suffi-
cient number and diverse population of mother-infant
pairs, (ii) use of 95% Confidence Intervals to present the
potential variability in prevalence of vitamin D deficiency/
insufficiency in CB, (iii) use of regression models for identi-
fying maternal factors that increase the risk for vitamin D
deficiency/insufficiency in infant at birth, and (iv) reporting
clinical characteristics of the neonates in association with
their vitamin D status at birth.
Conclusions
A significant number of infants, especially those born to
mothers of non-White race/ethnicity, younger age, and with
Table 2 Contribution of maternal characteristics in development of CB vitamin D deficiency and insufficiency
Variables CB vitamin D status
Insufficiency Deficiency
β +/−Std. Err P-value β+/−Std. Err P-value
White (1) / non-White (0) −0.204 +/− 0.076 0.01 −0.290+/−0.067 0.001
Age (years) −0.297+/− 0.076 0.001 −0.256 +/0.069 0.0001
Gravidity (number) 0.197 +/− 0.077 0.02 0.346 +/− 0.069 0.0001
Results from multiple regression analysis represented as regression coefficient (β) and Standard Error of better (Std. Err). CB vitamin D status: deficiency (n = 95),
insufficiency (n = 79), sufficient (n = 91)
Table 3 Characteristics of neonates during birth hospitalization
with respect to their CB vitamin D status
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a history of multiple pregnancies, are at risk for having insuffi-
cient and deficient levels of vitamin D in CB. Our data should
encourage pediatricians to supplement infants with vitamin D
especially considering the reported poor compliance with the
AAP’s recommendations by both, pediatricians and parents
[38]. Moreover, due to the high likelihood of vitamin D insuf-
ficiency/deficiency at birth, further studies may be required to
determine the role of implementing vitamin D supplementa-
tion with respect to the CB vitamin D status.
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